Epidemiology: A global picture of melioidosis.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

19 citing papers in PubMed.

1. Pathogens (Basel, Switzerland) · 2026
   Article
2. Optimal control and cost-effectiveness analysis for the human melioidosis model.Heliyon · 2024
   Article
3. A mathematical model analysis of the human melioidosis transmission dynamics with an asymptomatic case.Heliyon · 2022
   Article
4. When cancer drug resistance meets metabolomics (bulk, single-cell and/or spatial): Progress, potential, and perspective.Frontiers in oncology · 2022
   Review
5. A Highly Sensitive Time-Gated Fluorescence Immunoassay Platform Using Mn-Doped AgZnInS/ZnS Nanocrystals as Signal Transducers.Frontiers in physics · 2021
   Article
6. Drug screening to identify compounds to act as co-therapies for the treatment of Burkholderia species.PloS one · 2021
   Article
7. An in situ high-throughput screen identifies inhibitors of intracellularProceedings of the National Academy of Sciences of the United States of America · 2019
   Article
8. Melioidosis in the Torres Strait Islands, Australia: Exquisite Interplay between Pathogen, Host, and Environment.The American journal of tropical medicine and hygiene · 2019
   Article
9. Molecular determinants of Burkholderia pseudomallei BpeEF-OprC efflux pump expression.Microbiology (Reading, England) · 2018
   Article
10. Melioidosis in Bangladesh: A Clinical and Epidemiological Analysis of Culture-Confirmed Cases.Tropical medicine and infectious disease · 2018
    Review
11. Clinical, Bacteriologic, and Geographic Stratification of Melioidosis Emerges from the Sri Lankan National Surveillance Program.The American journal of tropical medicine and hygiene · 2018
    Article
12. Burkholderia pseudomallei distribution in Australasia is linked to paleogeographic and anthropogenic history.PloS one · 2018
    Article
13. Trimethoprim+Sulfamethoxazole Reduces Rates of Melioidosis in High-Risk Hemodialysis Patients.Kidney international reports · 2018
    Article
14. Development of Subunit Vaccines That Provide High-Level Protection and Sterilizing Immunity against Acute Inhalational Melioidosis.Infection and immunity · 2018
    Article
15. Pneumonia in the tropics.Respirology (Carlton, Vic.) · 2018
    Review
16. Structural characterisation of the capsular polysaccharide expressed by Burkholderia thailandensis strain E555:: wbiI (pKnock-KmR) and assessment of the significance of the 2-O-acetyl group in immune protection.Carbohydrate research · 2017
    Article
17. Rapid Filter-Based Detection and Culture of Burkholderia pseudomallei from Small Volumes of Urine.Journal of clinical microbiology · 2017
    Article
18. Isotype switching: Mouse IgG3 constant region drives increased affinity for polysaccharide antigens.Virulence · 2016
    Article
19. Influence of Biochemical Features ofJournal of global infectious diseases
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as